Dyslipidemia Study Investigating The Increase In "Good Cholesterol"

Completed · Phase 2

Conditions studied: Dyslipidaemias

In brief

An eight week comparison of the investigational drug GW590735, placebo, and the marketed drug fenofibrate intended to increase the levels of "good cholesterol" and decrease levels of "bad cholesterol" in healthy patients with low levels of good cholesterol and high levels of bad cholesterol.

Key facts

Study ID

NCT00169559

Run by

GlaxoSmithKline

People needed

250

Starts

2003-11-01

Expected to finish

2005-04-01

Last updated by the study team

2012-10-22

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• High-density lipoprotein cholesterol less than or equal to 45 mg/dL.
• Triglycerides greater than or equal to 120 mg/dL and less than or equal to 500 mg/dL.
• Women must be surgically sterile or postmenopausal.

You may not qualify if…

• Heart disease
• Diabetes

Where it is running

• GSK Investigational Site — Birmingham, Alabama, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Phoenix, Arizona, United States
• GSK Investigational Site — Scottsdale, Arizona, United States
• GSK Investigational Site — Beverly Hills, California, United States
• GSK Investigational Site — Healdsburg, California, United States
• GSK Investigational Site — Orange, California, United States
• GSK Investigational Site — Spring Valley, California, United States
• GSK Investigational Site — Walnut Creek, California, United States
• GSK Investigational Site — DeLand, Florida, United States
• GSK Investigational Site — Fort Lauderale, Florida, United States
• GSK Investigational Site — Fort Lauderdale, Florida, United States
• GSK Investigational Site — Fort Lauderdale, Florida, United States
• GSK Investigational Site — Hollywood, Florida, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Jacksonville, Florida, United States
• GSK Investigational Site — Pembroke Pines, Florida, United States
• GSK Investigational Site — Orland Park, Illinois, United States
• GSK Investigational Site — Evansville, Indiana, United States
• GSK Investigational Site — Indianapolis, Indiana, United States
• GSK Investigational Site — Iowa City, Iowa, United States
• GSK Investigational Site — Louisville, Kentucky, United States
• GSK Investigational Site — Auburn, Maine, United States
• GSK Investigational Site — Brooklyn Center, Minnesota, United States
• GSK Investigational Site — Omaha, Nebraska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.